Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 1/2024

21-08-2023 | Epistaxis | Rhinology

A novel frameshift mutation of the endoglin(ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family

Authors: Peng Li, Chunhai Gao, Yuda Wei, Xiangyu Zhao, Dezhong Sun, Liqiang Lin, Yangyang Yang, Qiang Shao, Huaiqing Lv

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2024

Login to get access

Abstract

Purpose

Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited disorder that involves epistaxis, mucocutaneous telangiectases, and visceral arteriovenous malformations (AVMs). This study aims to investigate the genetic causes in a Chinese family with HHT.

Methods

HHT was confirmed according to Curaçao’s diagnostic criteria. Three patients diagnosed with HHT and healthy members were recruited. Whole-exome sequencing (WES) and sanger sequencing were performed to define the patient’s genetically pathogenic factor.

Results

The proband presented with recurrent epistaxis, hepatopulmonary arteriovenous malformation, and adenocarcinoma. A novel frameshift mutation (c.1376_1377delAC, p.H459Lfs*41) of the ENG gene was revealed in affected individuals by WES. There was no report of this variant and predicted to be highly damaging by causing truncation of the ENG protein.

Conclusion

We report a novel variant in the ENG gene in Chinese that extends the mutational and phenotypic spectra of the ENG gene, and also demonstrates the feasibility of WES in the application of genetic diagnosis of HHT.
Literature
1.
go back to reference Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31–39CrossRefPubMed Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31–39CrossRefPubMed
2.
go back to reference Jelsig AM, Torring PM, Kjeldsen AD et al (2016) JP-HHT phenotype in Danish patients with SMAD4 mutations. Clin Genet 90:55–62CrossRefPubMed Jelsig AM, Torring PM, Kjeldsen AD et al (2016) JP-HHT phenotype in Danish patients with SMAD4 mutations. Clin Genet 90:55–62CrossRefPubMed
3.
go back to reference Kritharis A, Al-Samkari H, Kuter DJ (2018) Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective. Haematologica 103:1433–1443CrossRefPubMedPubMedCentral Kritharis A, Al-Samkari H, Kuter DJ (2018) Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective. Haematologica 103:1433–1443CrossRefPubMedPubMedCentral
4.
go back to reference McDonald J, Wooderchak-Donahue W, VanSant WC, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015) Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6:1CrossRefPubMedPubMedCentral McDonald J, Wooderchak-Donahue W, VanSant WC, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015) Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6:1CrossRefPubMedPubMedCentral
5.
7.
go back to reference Kroon S, Snijder RJ, Faughnan ME, Mager HJ (2018) Systematic screening in hereditary hemorrhagic telangiectasia: a review. Curr Opin Pulm Med 24:260–268CrossRefPubMed Kroon S, Snijder RJ, Faughnan ME, Mager HJ (2018) Systematic screening in hereditary hemorrhagic telangiectasia: a review. Curr Opin Pulm Med 24:260–268CrossRefPubMed
8.
go back to reference Sabbà C, Pasculli G, Lenato GM et al (2007) Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5:1149–1157CrossRefPubMed Sabbà C, Pasculli G, Lenato GM et al (2007) Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5:1149–1157CrossRefPubMed
9.
go back to reference Wooderchak-Donahue WL, McDonald J, O’Fallon B et al (2013) BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93:530–537CrossRefPubMedPubMedCentral Wooderchak-Donahue WL, McDonald J, O’Fallon B et al (2013) BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93:530–537CrossRefPubMedPubMedCentral
10.
go back to reference Pawlikowska L, Nelson J, Guo DE et al (2015) The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. Am J Med Genet A 167:1262–1267CrossRefPubMedPubMedCentral Pawlikowska L, Nelson J, Guo DE et al (2015) The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. Am J Med Genet A 167:1262–1267CrossRefPubMedPubMedCentral
11.
go back to reference Iyer VN, Apala DR, Pannu BS et al (2018) Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding. Mayo Clin Proc 93:155–166CrossRefPubMed Iyer VN, Apala DR, Pannu BS et al (2018) Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding. Mayo Clin Proc 93:155–166CrossRefPubMed
12.
go back to reference Bayrak R, Haltas H, Yenidunya S (2012) The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol 7:9CrossRefPubMedPubMedCentral Bayrak R, Haltas H, Yenidunya S (2012) The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol 7:9CrossRefPubMedPubMedCentral
13.
go back to reference Fatima N, Cohen C, Lawson D, Siddiqui MT (2011) TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol 119:127–133CrossRefPubMed Fatima N, Cohen C, Lawson D, Siddiqui MT (2011) TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol 119:127–133CrossRefPubMed
15.
go back to reference Liu DT, Frohne A, Koenighofer M et al (2020) Plasma VEGF - a candidate biomarker for response to treatment with bevacizumab in HHT patients. Rhinology 58:18–24PubMed Liu DT, Frohne A, Koenighofer M et al (2020) Plasma VEGF - a candidate biomarker for response to treatment with bevacizumab in HHT patients. Rhinology 58:18–24PubMed
16.
go back to reference Albinana V, Zafra MP, Colau J et al (2017) Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1. BMC Med Genet 18:20CrossRefPubMedPubMedCentral Albinana V, Zafra MP, Colau J et al (2017) Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1. BMC Med Genet 18:20CrossRefPubMedPubMedCentral
Metadata
Title
A novel frameshift mutation of the endoglin(ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family
Authors
Peng Li
Chunhai Gao
Yuda Wei
Xiangyu Zhao
Dezhong Sun
Liqiang Lin
Yangyang Yang
Qiang Shao
Huaiqing Lv
Publication date
21-08-2023
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 1/2024
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-023-08186-4

Other articles of this Issue 1/2024

European Archives of Oto-Rhino-Laryngology 1/2024 Go to the issue